Assessment of the association of baseline anti-CarbV and anti-MCV antibodies with response to treatment and radiographic progression in an RA population treated with either methotrexate or baricitinib: post-hoc analyses from RA-BEGIN.
Pedro López-RomeroLorena Martinez-GamboaHolger BangInmaculada de la TorreThorsten HolzkämperEugen FeistPublished in: Arthritis research & therapy (2020)
High titers of anti-CarbV IgA and IgG isotypes, but not anti-MCV isotypes, may be useful prognostic biomarkers for identifying the likelihood of the response to treatment and structural damage progression in patients with RA.